Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Acute decompensated heart failure

Joe Nemeth
CMAJ July 17, 2007 177 (2) 175; DOI: https://doi.org/10.1503/cmaj.1070053
Joe Nemeth MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2007 Canadian Medical Association or its licensors

Although Larry Allen and Christopher O'Connor's review of the management of acute decompensated heart failure1 was generally well written, I have reservations about their interpretation of the evidence concerning the role of loop diuretics, specifically furosemide, and their recommendations regarding furosemide's place in the treatment of acute decompensated heart failure.

First, I disagree with their implication that congestion indicates volume overload and their suggestion that clinicians consequently “rely heavily on diuretic therapy.” Such statements help to perpetuate the misuse of furosemide in acute decompensated heart failure. Up to 50% of patients with acute cardiogenic pulmonary edema are euvolemic, and treatment should emphasize fluid redistribution rather than fluid removal. Second, although diuretics have been weakly shown to decrease mortality,2 if they are relied upon exclusively in acute care in hospitals they have the opposite effect. Third, in acute decompensated heart failure caused by high afterload (e.g., hypertensive emergencies), renal perfusion can drop by as much as 80% and furosemide will produce a delayed diuretic effect 30–120 minutes after administration. Finally, there is very little evidence for any beneficial hemodynamic effect of furosemide. In fact, many studies have shown that furosemide is responsible for adverse hemodynamic effects in patients with acute decompensated heart failure, because it causes an initial release of catecholamines and activates the renin–angiotensin system.3–5

In conclusion, I disagree with the authors' summary that “therapy with a loop diuretic currently forms the foundation” of treatment of acute decompensated heart failure despite good evidence that loop diuretics should be reserved for use as third-line agents behind therapies to reduce preload and afterload (e.g., nitroglycerin and angiotensin-converting-enzyme inhibitors) in acute decompensated heart failure in the hospital setting.

Footnotes

  • Competing interests: None declared.

REFERENCES

  1. 1.↵
    Allen LA, O'Connor CM. Management of acute decompensated heart failure. CMAJ 2007;176(6):797-805.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Faris R, Flather M, Purcell H, et al. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 2002;82(2):149-58.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Nelson GI, Ahuja RC, Silke B, et al. Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction. Eur Heart J 1983;4(10):706-11.
    OpenUrlAbstract/FREE Full Text
  4. 4.
    Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985;103(1):1-6.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Kraus PA, Lipman J, Becker PJ. Acute preload effects of furosemide. Chest 1990;98(1):124-8.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 177 (2)
CMAJ
Vol. 177, Issue 2
17 Jul 2007
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acute decompensated heart failure
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Acute decompensated heart failure
Joe Nemeth
CMAJ Jul 2007, 177 (2) 175; DOI: 10.1503/cmaj.1070053

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Acute decompensated heart failure
Joe Nemeth
CMAJ Jul 2007, 177 (2) 175; DOI: 10.1503/cmaj.1070053
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Coexisting failures do not diminish the stature of a giant
  • Dare we hope
  • Highlighting obesity as a risk factor for endometrial cancer
Show more Letters

Similar Articles

Collections

  • Topics
    • Emergency medicine
    • Cardiology: heart failure

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire